Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Am J Kidney Dis. 2022 Jan 25;80(2):207–214. doi: 10.1053/j.ajkd.2021.12.008

Table 4.

Association between neighborhood-level risk factors and CKD co-morbidities and healthcare utilization

Health Characteristic Outcome Odds Ratio (95% CI) and p-value
Median Neighborhood Income < $32,721 per year (n=578) Area Deprivation Index ≥ 113.45 (n=559)
Unadjusted Adjusted** Unadjusted Adjusted**
Short Stature* 1.77 (1.06, 2.96) p=0.03 1.34 (0.75, 2.40) p= 0.32 1.67 (0.86, 3.23) p= 0.13 1.38 (0.65, 2.92) p= 0.40
Obese α 1.14 (0.70, 1.85) p= 0.59 0.74 (0.44, 1.28) p= 0.28 1.10 (0.57, 2.10) p= 0.78 0.66 (0.31, 1.34) p= 0.24
Hypertension β 1.40 (0.96, 2.05) p= 0.08 1.43 (0.94, 2.19) p= 0.10 1.20 (0.72, 1.99) p= 0.49 1.03 (0.59, 1.81) p= 0.92
Hospitalized in Last Year 1.55 (1.03, 2.35) p= 0.04 1.71 (1.08, 2.71) p= 0.02 1.04 (0.59, 1.84) p= 0.89 1.15 (0.62, 2.14) p= 0.66
Emergency Room Visit in Last Year 1.71 (1.16, 2.52) p= 0.01 1.56 (1.02, 2.40) p= 0.04 1.24 (0.74, 2.07) p= 0.42 1.00 (0.57, 1.78) p= 0.99
Preemptive Transplant 0.47 (0.24,0.96) p= 0.04 0.81 (0.37, 1.77) p= 0.59 0.31 (0.10, 0.97) p= 0.04 0.51 (0.15, 1.72) p= 0.28
*

height z-score < −1.88,

α

body mass index z-score > 1.65.

β

systolic blood pressure ≥95th percentile or a self-report diagnosis and at least one anti-hypertensive medication

**

Model includes participant race, ethnicity, sex, and family income category